LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells
Advanced Science · 2023
DOI: 10.1002/advs.202204599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Ting La und 21 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Institute, Henan Provincial and Zhengzhou City Key laboratory of Non-coding RNA and Cancer Metabolism, Henan International Joi…. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms, RNA, Long Noncoding, Cyclin-Dependent Kinase Inhibitor p27. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Excellent Youth Foundation of He'nan Scientific Committee, China; Hunter Medical Research Institute (T. La), Australia; the Cancer Council NSW.
Abstract (Originalsprache)
P53 inactivation occurs in about 50% of human cancers, where p53‐driven p21 activity is devoid and p27 becomes essential for the establishment of the G1/S checkpoint upon DNA damage. Here, this work shows that the E2F1‐responsive lncRNA LIMp27 selectively represses p27 expression and contributes to proliferation, tumorigenicity, and treatment resistance in p53‐defective colon adenocarcinoma (COAD) cells. LIMp27 competes with p27 mRNA for binding to cytoplasmically localized hnRNA0, which otherwise stabilizes p27 mRNA leading to cell cycle arrest at the G0/G1 phase. In response to DNA damage, LIMp27 is upregulated in both wild‐type and p53‐mutant COAD cells, whereas cytoplasmic hnRNPA0 is only increased in p53‐mutant COAD cells due to translocation from the nucleus. Moreover, high LIMp27 expression is associated with poor survival of p53‐mutant but not wild‐type p53 COAD patients. These results uncover an lncRNA mechanism that promotes p53‐defective cancer pathogenesis and suggest that LIMp27 may constitute a target for the treatment of such cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research Institute, Henan Provincial and Zhengzhou City Key laboratory of Non-coding RNA and Cancer Metabolism, Henan International Join Laboratory of Non-coding RNA and Metabolism in Cancer, Henan Provinc…
- Noncoding Cancer Biomarkers and Therapeutics Group, Cancer Detection & Therapy Research Program, Hunter Medical Research Institute, Callaghan, New South Wales, 2305, Australia.
- School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, New South Wales, 2308, Australia.
- National-Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
- Institute of Medicinal Biotechnology, Jiangsu College of Nursing, Huai'an, Jiangsu, 223300, China.
- Institute of Future Agriculture, Northwest A&F University, Yangling, Shaanxi, 712100, China.
ORCID-Profile: Feng-Min Shao, Xu Dong Zhang, Lei Jin
Förderung
- National Natural Science Foundation of China
- Excellent Youth Foundation of He'nan Scientific Committee
- China; Hunter Medical Research Institute (T. La), Australia; the Cancer Council NSW
- Australia; the National Health and Medical Research Council
Zitieren
APA
La, T., Chen, S., Zhao, X. H., Zhou, S., Xu, R., Teng, L., Zhang, Y. Y., Ye, K., Xu, L., Guo, T., Jamaluddin, M. F., Feng, Y. C., Tang, H. J., Wang, Y., Xu, Q., Gu, Y., Cao, H., Liu, T., Thorne, R. F., …, & Jin, L. (2023). LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells. Advanced Science. https://doi.org/10.1002/advs.202204599
Vancouver
La T, Chen S, Zhao XH, Zhou S, Xu R, Teng L, et al. LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells. Advanced Science. 2023. doi:10.1002/advs.202204599
BibTeX
@article{La2023,
author = {La, Ting and Chen, Song and Zhao, Xiao Hong and Zhou, Shuai and Xu, Ran and Teng, Liu and Zhang, Yuan Yuan and Ye, Kaihong and Xu, Liang and Guo, Tao and Jamaluddin, Muhammad Fairuz and Feng, Yu Chen and Tang, Hai Jie and Wang, Yanliang and Xu, Qin and Gu, Yue and Cao, Huixia and Liu, Tao and Thorne, Rick F and Shao, Feng-Min and Zhang, Xu Dong and Jin, Lei},
title = {LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202204599}
}
EUVIMED